Skip to main content

Illumina Names Several Partners for New TruSeq, Nextera Program

NEW YORK (GenomeWeb News) – Illumina today said that it has launched a partnership program aimed at developing automation methods for its TruSeq and Nextera Sample Preparation kits.

The initial partners in the program include Beckman Coulter Life Sciences, PerkinElmer, Eppendorf, Tecan, and Hamilton Robotics. Under the partnerships, sample prep kits sold by Illumina will be automated by the partners, who will develop, distribute, and install methods on the customers' instruments and provide technical support.

Illumina makes TruSeq Sample Prep and Exome Enrichment Kits for DNA, RNA, and small RNA sequencing applications. Its Nextera XT DNA sample preparation kit is used for preparing and sequencing small genomes, PCR amplicons, and plasmids.

Illumina said that it will assist the partners in developing, testing, and promoting the automated methods. It expects automated methods for the TruSeq RNA Sample Preparation kits to be available by the end of the second quarter of this year with additional methods for other TruSeq and Nextera kits to follow.

Financial and other terms of the partnerships were not disclosed.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.